 |
Previous Article | Next Article 
The Journal of Neuroscience, May 1, 2002, 22(9):3531-3542
Inhibition of Protein Kinase C Prevents Purkinje Cell Death But
Does Not Affect Axonal Regeneration
Abdel M.
Ghoumari1,
Rosine
Wehrlé1,
Chris
I.
De Zeeuw2,
Constantino
Sotelo1, and
Isabelle
Dusart1
1 Institut National de la Santé et de la
Recherche Médicale Unité 106, Hôpital de la
Salpêtrière, 75651 Paris Cedex 13, France, and
2 Department of Anatomy, Neuroscience Institute, Faculteit
der Geneeskunde en Gezondheidswetenschappen, Erasmus, University
Rotterdam, 3000 DR Rotterdam, The Netherlands
In organotypic cultures, mouse Purkinje cells regenerate their
axons from embryonic day 18 (E18) to postnatal day 0 (P0), die of
apoptosis between P1 and P7, and survive but do not regenerate at P10.
This particular behavior of Purkinje cells did not allow us to find out
when the developmental switch between regeneration and lack of
regeneration occurs. This work was undertaken to suppress Purkinje cell
apoptosis and to investigate whether the same molecules that prevent
apoptosis could also influence axonal growth, regeneration, or both. We
show that brain-derived neurotrophic factor, neurotrophin 3, and
insulin-like growth factor I have marginal effects on P3 Purkinje cell
death. The use of Gö6976 [a protein kinase C (PKC) inhibitor] or a transgenic mouse line, in which a pseudosubstrate PKC
inhibitor has been specifically targeted to Purkinje cells, prevents
the massive Purkinje cell death in P3 organotypic cultures. In
addition, Gö6976 promotes axotomized Purkinje cell survival up to
P7. Thus, the inhibition of PKC activity is able to prevent Purkinje
cell apoptosis in organotypic cultures. Furthermore, Gö6976
increases the outgrowth of dendrites and axon collateralization, as
shown after gene gun enhanced green fluorescent protein transfection. In contrast, PKC inhibitors do not influence the axonal regenerative capability of Purkinje cell during development; the latter decreases between E18 and P7 after the same time course in control and
Gö6976-treated slices. Thus, because inhibition of PKC prevents
Purkinje cell death but does not affect axonal regeneration, these two
events (cell death and axonal regeneration) seem to be differentially regulated.
Key words:
axotomy; apoptosis; trophic factor; cerebellum; PKC
inhibitor; development
Copyright © 2002 Society for Neuroscience 0270-6474/02/2293531-12$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu
Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System
Endocr. Rev.,
June 1, 2007;
28(4):
387 - 439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Kimpo and J. L. Raymond
Impaired Motor Learning in the Vestibulo-Ocular Reflex in Mice with Multiple Climbing Fiber Input to Cerebellar Purkinje Cells
J. Neurosci.,
May 23, 2007;
27(21):
5672 - 5682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, J. Imitola, E. Y. Snyder, and R. L. Sidman
Neural stem cells rescue nervous purkinje neurons by restoring molecular homeostasis of tissue plasminogen activator and downstream targets.
J. Neurosci.,
July 26, 2006;
26(30):
7839 - 7848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Ghoumari, C. Piochon, C. Tomkiewicz, B. Eychenne, C. Levenes, I. Dusart, M. Schumacher, and E. E. Baulieu
Neuroprotective effect of mifepristone involves neuron depolarization
FASEB J,
July 1, 2006;
20(9):
1377 - 1386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Lister, D. J. Autelitano, A. Jenkins, R. D. Hannan, and K. E. Sheppard
Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: A possible role for SGK1
Cardiovasc Res,
June 1, 2006;
70(3):
555 - 565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, Y. Ma, Y. D. Teng, K. Zheng, T. K. Vartanian, E. Y. Snyder, and R. L. Sidman
Purkinje neuron degeneration in nervous (nr) mutant mice is mediated by a metabolic pathway involving excess tissue plasminogen activator
PNAS,
May 16, 2006;
103(20):
7847 - 7852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Boukhtouche, S. Janmaat, G. Vodjdani, V. Gautheron, J. Mallet, I. Dusart, and J. Mariani
Retinoid-Related Orphan Receptor {alpha} Controls the Early Steps of Purkinje Cell Dendritic Differentiation
J. Neurosci.,
February 1, 2006;
26(5):
1531 - 1538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Verbeek, M. A. Knight, G. G. Harmison, K. H. Fischbeck, and B. W. Howell
Protein kinase C gamma mutations in spinocerebellar ataxia 14 increase kinase activity and alter membrane targeting
Brain,
February 1, 2005;
128(2):
436 - 442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bouslama-Oueghlani, R. Wehrle, C. Sotelo, and I. Dusart
The Developmental Loss of the Ability of Purkinje Cells to Regenerate Their Axons Occurs in the Absence of Myelin: An In Vitro Model to Prevent Myelination
J. Neurosci.,
September 10, 2003;
23(23):
8318 - 8329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Ghoumari, I. Dusart, M. El-Etr, F. Tronche, C. Sotelo, M. Schumacher, and E.-E. Baulieu
Mifepristone (RU486) protects Purkinje cells from cell death in organotypic slice cultures of postnatal rat and mouse cerebellum
PNAS,
June 24, 2003;
100(13):
7953 - 7958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gianola, T. Savio, M. E. Schwab, and F. Rossi
Cell-Autonomous Mechanisms and Myelin-Associated Factors Contribute to the Development of Purkinje Axon Intracortical Plexus in the Rat Cerebellum
J. Neurosci.,
June 1, 2003;
23(11):
4613 - 4624.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|